Poltreg S.A. Logo

Poltreg S.A.

ISIN: PLPLTRG00038 | Ticker: PTG | LEI: 259400XSAJTERJ42VZ86

About Poltreg S.A.

Company Description

Poltreg S.A. is a biotechnology company based in Poland that focuses on developing innovative therapies for autoimmune diseases. The company specializes in using T-regulatory cells (TREGs) to develop a new generation of medicines aimed at treating autoimmune diseases , such as diabetes type 1 and multiple sclerosis. Poltreg S.A. is currently conducting various stages of research and development projects in these areas to offer medical solutions to those suffering from autoimmune diseases . The company's strong commitment to research and development is reinforced by its team of qualified scientists and researchers dedicated to developing new technologies and techniques to improve health outcomes.

Year founded


Served area



Wały Piastowskie 1/Lok.1508, 80-855 Gdańsk – Poland

Filings & Publications

Shareholder information

Shares outstanding



Nov. 1, 2021

Stock exchange(s)

Warsaw Stock Exchange

Contact Investor Relations department


Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.